Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Safety and Performance of the HARPOON™ Beating Heart Mitral Valve Repair System; a Multi-center Post-market Study (ASCEND)

NCT04382612 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT04382612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04382612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Safety and Performance of the HARPOON™ Beating Heart Mitral Valve Repair System; a Multi-center Post-market Study (ASCEND)
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Terminated
Start date
October 2, 2020
Completion date
December 1, 2022
Enrollment
42 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation